Suchergebnisse - "Xia, Zhongjun"

PubPharm (10)

1

Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma

enthalten in: Annals of hematology | 2022

von Guan, J. | Sun, F. | Wang, J. | +11

2

A study of carfilzomib and dexamethasone in patients with relapsed and refractory multiple myeloma in China

enthalten in: International journal of hematology | 2021

von Du, J. | Fang, B. | Li, J. | +16

3

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

4

Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study

enthalten in: International journal of hematology | 2019

von Li, C. | Cai, X. | Chen, X. | +3

5

Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type

enthalten in: Oncology letters | 2016

von Wang, H. | Li, P. | Zhang, X. | +3

6

Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells In Vitro, In Vivo, and Ex Vivo

enthalten in: Molecular cancer therapeutics | 2016

von Chen, Z. | Chen, Y. | Xu, M. | +8

7

High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type

enthalten in: Annals of hematology | 2015

von Wang, H. | Li, P. | Wang, L. | +4

8

New prognostic model for extranodal natural killer/T cell lymphoma, nasal type

enthalten in: Annals of hematology | 2014

von Cai, Q. | Luo, X. | Zhang, G. | +6

9

Efficacy and safety of transdermal fentanyl for treatment of oral mucositis pain caused by chemotherapy

enthalten in: Expert opinion on pharmacotherapy | 2008

von Cai, Q. | Huang, H. | Sun, X. | +4

10

Preliminary outcome of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin’s lymphoma: single institution experience

enthalten in: The Chinese-german journal of clinical oncology | 2006

von Wang, B. | Huang, H. | Bu, Q. | +10

1
[1]